Skip to main content

Articles

Page 3 of 27

  1. Adulterants, such as fentanyl and xylazine, among others, are present in a high percentage of the illicit drug supply, increasing the risk for overdose and other adverse health events among people who use drug...

    Authors: Megan K. Reed, Elias Borne, Tracy Esteves Camacho, Morgan Kelly and Kristin L. Rising
    Citation: Harm Reduction Journal 2024 21:26
  2. Due to shared modes of transmission, coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is common, and HBV vaccination is recommended for all persons with HCV who remain susceptible to HBV. T...

    Authors: Catherine Campusano, Rachel Kanner, Claire McDonell, Meghan Morris, Maria Duarte and Jennifer C. Price
    Citation: Harm Reduction Journal 2024 21:25
  3. Against the backdrop of North America’s overdose crisis, most overdose deaths are occurring in housing environments, largely due to individuals using drugs alone. Overdose deaths in cities remain concentrated ...

    Authors: Taylor Fleming, Jade Boyd, Koharu Loulou Chayama, Kelly R. Knight and Ryan McNeil
    Citation: Harm Reduction Journal 2024 21:24
  4. Hepatitis C virus (HCV) disproportionately affects rural communities, where health services are geographically dispersed. It remains unknown whether proximity to a syringe services program (SSP) is associated ...

    Authors: Eric Romo, Thomas J. Stopka, Bill M. Jesdale, Bo Wang, Kathleen M. Mazor and Peter D. Friedmann
    Citation: Harm Reduction Journal 2024 21:23
  5. Many physicians including emergency medicine physicians report insufficient training and education on prescribing buprenorphine for opioid use disorder. As emergency departments implement buprenorphine inducti...

    Authors: Cara Marie Borelli and Han Tony Gao
    Citation: Harm Reduction Journal 2024 21:22
  6. Although cannabis use incidence, societal acceptance, and legislation all trend positively, cannabis remains federally illegal in the USA. Prior studies have revealed that patients are reluctant to disclose th...

    Authors: Daniel D. King, Christopher J. Gill, Carey S. Cadieux and Neha Singh
    Citation: Harm Reduction Journal 2024 21:21
  7. Opioid-related mortality is a rising public health concern in France, where opioids were in 2021 implicated in 75% of overdose deaths. Opioid substitution treatment (OST) was implicated in almost half of death...

    Authors: Aurélie Aquizerate, Morgane Rousselet, Axel Cochard, Marylène Guerlais, Marie Gerardin, Emilie Lefebvre, Mélanie Duval, Edouard-Jules Laforgue and Caroline Victorri-Vigneau
    Citation: Harm Reduction Journal 2024 21:20
  8. Over 180,000 people use crack cocaine in England, yet provision of smoking equipment to support safer crack use is prohibited under UK law. Pipes used for crack cocaine smoking are often homemade and/or in sho...

    Authors: Magdalena Harris, Jenny Scott, Vivian Hope, Joanna Busza, Sedona Sweeney, Andrew Preston, Mat Southwell, Niamh Eastwood, Cedomir Vuckovic, Caitlynne McGaff, Ian Yoon, Louise Wilkins, Shoba Ram, Catherine Lord, Philippe Bonnet, Peter Furlong…
    Citation: Harm Reduction Journal 2024 21:19
  9. Addressing xylazine harms are now a critical harm reduction priority, but relatively little epidemiological information exists to determine prevalence, magnitude, and correlates of xylazine use or related outc...

    Authors: Danielle German, Becky Genberg, Olivia Sugarman, Brendon Saloner, Anne Sawyer, Jennifer L. Glick, Molly Gribbin and Colin Flynn
    Citation: Harm Reduction Journal 2024 21:18
  10. Early in the COVID-19 pandemic, there was an urgent need to establish isolation spaces for people experiencing homelessness who were exposed to or had COVID-19. In response, community agencies and the City of ...

    Authors: Gillian Kolla, Chowdhury Nishwara Tarannum, Kaitlin Fajber, Fiqir Worku, Kris Norris, Cathy Long, Raphaela Fagundes, Anne Rucchetto, Eileen Hannan, Richard Kikot, Michelle Klaiman, Michelle Firestone, Ahmed Bayoumi, Gab Laurence and Kate Hayman
    Citation: Harm Reduction Journal 2024 21:17
  11. The rise in injection drug use in the USA has led to an increase in injection site infections. We performed a national survey of people who use drugs to evaluate common drug use preparation, harm reduction pra...

    Authors: Laura R. Marks, Michael J. Durkin, Kelly Ayres and Matthew Ellis
    Citation: Harm Reduction Journal 2024 21:16
  12. Consistent reports from health professionals suggest that heroin is commonly used by patients undergoing opioid maintenance treatment (OMT) in France, potentially jeopardizing their recovery process. However, ...

    Authors: Eric Janssen, Mike Vuolo, Stanislas Spilka and Guillaume Airagnes
    Citation: Harm Reduction Journal 2024 21:15
  13. Over the past decade in the USA, increases in overdose rates of cocaine and psychostimulants with opioids were highest among Black, compared to White, populations. Whether fentanyl has contributed to the rise ...

    Authors: Angela T. Estadt, Brian N. White, JaNelle M. Ricks, Kathryn E. Lancaster, Staci Hepler, William C. Miller and David Kline
    Citation: Harm Reduction Journal 2024 21:13
  14. The first Harm Reduction DACH Conference [DACH = D (Germany), A (Austria), CH (Switzerland)] took place in Vienna on June 23rd, 2023, and focused on tobacco harm reduction. It is the first conference bringing ...

    Authors: Larissa Steimle, Simon Fleißner, Hans Haltmayer, Thilo Beck, Alfred Springer and Heino Stöver
    Citation: Harm Reduction Journal 2024 21:12
  15. Shifts in the US drug supply, including the proliferation of synthetic opioids and emergence of xylazine, have contributed to the worsening toll of the overdose epidemic. Drug checking services offer a critica...

    Authors: Kyle J. Moon, Heather D. Whitehead, Anne Trinh, Kathryn A. Hasenstab, Kathleen L. Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman and Saira Nawaz
    Citation: Harm Reduction Journal 2024 21:11
  16. While women living with HIV (WLWH) are twice as likely to report severe or undertreated chronic pain compared to men, little is known about pain among WLWH. Our goal was to characterize the correlates of pain ...

    Authors: Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Krüsi and Kathleen Deering
    Citation: Harm Reduction Journal 2024 21:10
  17. Each year, thousands of migrants enter the EU. Data on drug use in migrant populations are scarce and inconclusive. However, several risk factors make them particularly vulnerable to engaging in problematic dr...

    Authors: Lena van Selm, Trenton M. White, Camila A. Picchio, Ana Requena-Méndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert and Jeffrey V. Lazarus
    Citation: Harm Reduction Journal 2024 21:9
  18. Programmatic and financial sustainability of health responses dependent on donor funding has risen as a major concern. In the HIV field in particular, it generated a number of instruments and assessments on su...

    Authors: Raminta Stuikyte, Ivan Varentsov, Catherine Cook and Sergii Dvoriak
    Citation: Harm Reduction Journal 2024 21:7

    The Correction to this article has been published in Harm Reduction Journal 2024 21:27

  19. Globally, People Who Inject Drugs (PWID) have limited healthcare, treatment, and prevention services, and they frequently experience stigma and negative attitudes toward healthcare providers when accessing ser...

    Authors: Cynthia Semá Baltazar, Auria Ribeiro Banze, Jessica Seleme and Makini Boothe
    Citation: Harm Reduction Journal 2024 21:6
  20. With growing rates of unregulated drug toxicity death and concerns regarding COVID-19 transmission among people who use drugs, in March 2020, prescribed safer supply guidance was released in British Columbia. ...

    Authors: Heather Palis, Beth Haywood, Jenny McDougall, Chloé G. Xavier, Roshni Desai, Samuel Tobias, Heather Burgess, Max Ferguson, Lisa Liu, Brooke Kinniburgh, Amanda K. Slaunwhite, Alexis Crabtree and Jane A. Buxton
    Citation: Harm Reduction Journal 2024 21:5
  21. HIV self-testing (HIVST) could increase HIV testing access among people who inject drugs (PWID), and secondary distribution (i.e., peer-delivery) of HIVST kits in PWID social networks could further expand cove...

    Authors: Heather A. Pines, William H. Eger, Britt Skaathun, Carlos F. Vera, Alicia Harvey-Vera, Gudelia Rangel, Steffanie A. Strathdee and Angela R. Bazzi
    Citation: Harm Reduction Journal 2024 21:4
  22. Women with substance-use issues are overrepresented in prison. Research on women’s recidivism often focuses on offending behaviour rather than the health and social circumstances women are experiencing when re...

    Authors: Layla Maree Edwards, Sungwon Chang, Reem Zeki, Sacha Kendall Jamieson, Julia Bowman, Craig Cooper and Elizabeth Sullivan
    Citation: Harm Reduction Journal 2024 21:2
  23. Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understa...

    Authors: Eloise W. Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M. Yamada, Syeda Masharab Jillani, Julia H. Arnsten and Deepika E. Slawek
    Citation: Harm Reduction Journal 2024 21:1
  24. Medications for opioid use disorder (OUD) are effective at preventing overdose and infectious disease but are vastly under-prescribed in the US. For decades, prescribers faced additional training and regulatio...

    Authors: Berkeley Franz, Lindsay Y. Dhanani, O. Trent Hall, Daniel L. Brook, Janet E. Simon and William C. Miller
    Citation: Harm Reduction Journal 2023 20:180
  25. Lives lost in North America due to the unregulated drug poisoning emergency are preventable and those who survive an opioid overdose may suffer long-term disability. Rates of opioid overdose more than doubled ...

    Authors: Max Ferguson, Paul Choisil, Jessica Lamb, Charlene Burmeister, Cheri Newman, Kurt Lock, Samuel Tobias, Lisa Liu and Jane A. Buxton
    Citation: Harm Reduction Journal 2023 20:178
  26. Harm reduction strategies can decrease morbidity and mortality associated with substance use. Various barriers limit conversation around substance use between clinicians and patients. Graphic medicine techniqu...

    Authors: Leah H. Harvey, Westyn Branch-Elliman, Jacqueline Boudreau, Samantha K. Sliwinski, Allen L. Gifford, Minh Q. Ho, Elizabeth Dinges and Justeen Hyde
    Citation: Harm Reduction Journal 2023 20:177
  27. Rave music parties (RMP) are a world-wide socio-cultural phenomenon, where people listen to rave music while frequently consuming psychedelic drugs. Epidemiological studies have emphasized the hazardous conseq...

    Authors: Yula Milshteyn and Moshe Bensimon
    Citation: Harm Reduction Journal 2023 20:176
  28. Fentanyl test strips (FTS) are a commonly deployed tool in drug checking, used to test for the presence of fentanyl in street drug samples prior to consumption. Previous reports indicate that in addition to fe...

    Authors: Kathleen L. Hayes and Marya Lieberman
    Citation: Harm Reduction Journal 2023 20:175
  29. Perception of drug adulteration has increased in Mexico, but there is little research on adulterants and toxicity. The aim of this study was to identify drug composition in an electronic music outdoor festival...

    Authors: Silvia L. Cruz, Miguel Bencomo-Cruz, María E. Medina-Mora, Fabiola Vázquez-Quiroz and Clara Fleiz-Bautista
    Citation: Harm Reduction Journal 2023 20:174
  30. BUP-XR (SUBLOCADE®) is the first buprenorphine extended-release subcutaneous injection approved in the USA for monthly treatment of moderate-to-severe opioid use disorder (OUD). Among patients with OUD, those who...

    Authors: Mark K. Greenwald, Katharina L. Wiest, Barbara R. Haight, Celine M. Laffont and Yue Zhao
    Citation: Harm Reduction Journal 2023 20:173
  31. This paper applies the theory of change model (Kotter in Harv Bus Rev 2:59–67, 1995; Moore et al. in Viet Nam J Public Health 1(1):66–75, 2013) to describe the pathway that lead to Australia’s first pill testi...

    Authors: David Caldicott, Toni Makkai, Malcolm McLeod, Stephanie Tzanetis and Gino Vumbaca
    Citation: Harm Reduction Journal 2023 20:172
  32. Bystander administration of naloxone is a critical strategy to mitigate opioid overdose mortality. To ensure bystanders’ willingness to carry and administer naloxone in response to a suspected overdose, it is ...

    Authors: Katherine R. Marks, Douglas R. Oyler, Justin C. Strickland, Jody Jaggers, Monica F. Roberts, Dustin K. Miracle, Chase Barnes, Feitong Lei, Amanda Smith, Eric Mackin, Martika C. Martin and Patricia R. Freeman
    Citation: Harm Reduction Journal 2023 20:171
  33. The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis has been data monito...

    Authors: Melissa Perri, Triti Khorasheh, David Edward-Ooi Poon, Nat Kaminski, Sean LeBlanc, Leticia Mizon, Ashley Smoke, Carol Strike and Pamela Leece
    Citation: Harm Reduction Journal 2023 20:169
  34. The experiences and perceived support needs of harm reduction workers in the USA have been understudied. While previous research has explored staff burnout and role-related stress, there is a research gap arou...

    Authors: Katherine Hill, Katherine Dunham, Lauretta E. Grau and Robert Heimer
    Citation: Harm Reduction Journal 2023 20:168
  35. Interpersonal violence and opioid use disorder are significant and intersecting public health concerns in the USA. The current study evaluated the consequences associated with opioid use (e.g., physical, socia...

    Authors: Prachi H. Bhuptani, Lindsay M. Orchowski, Shannon R. Forkus, Noam G. Newberger and Nicole H. Weiss
    Citation: Harm Reduction Journal 2023 20:167
  36. Overdoses have surged in rural areas in the U.S. and globally for years, but harm reduction interventions have lagged. Overdose education and naloxone distribution (OEND) programs reduce overdose mortality, bu...

    Authors: Zora Kesich, Umedjon Ibragimov, Kelli Komro, Kenneth Lane, Melvin Livingston, April Young and Hannah L. F. Cooper
    Citation: Harm Reduction Journal 2023 20:166
  37. Women who inject drugs in Ukraine are disproportionately burdened by HIV. To help address the needs of this population, a greater understanding of how interventions may uniquely benefit women who inject drugs ...

    Authors: John Mark Wiginton, Robert Booth, Laramie R. Smith, Sajina Shakya, Cristina Espinosa da Silva, Thomas L. Patterson and Eileen V. Pitpitan
    Citation: Harm Reduction Journal 2023 20:165
  38. In Kenya, violence is common among people who inject drugs (PWID) living with HIV and their sexual and injecting partners and may lead to decreased uptake of HIV services, increased HIV risk behaviors, and inc...

    Authors: Sai Win Kyaw Htet Aung, Hanley Kingston, Loice W. Mbogo, Betsy Sambai, Aliza Monroe-Wise, Natasha T. Ludwig-Barron, David Bukusi, William Sinkele, Esther Gitau, Sarah Masyuko, Joshua T. Herbeck, Carey Farquhar and Brandon L. Guthrie
    Citation: Harm Reduction Journal 2023 20:164
  39. The rising rates of drug use-related complications call for a paradigm shift in the care for people who use drugs. While addiction treatment and harm reduction have historically been siloed in the US, co-locat...

    Authors: Margaret Shang, Brent Thiel, Jane M. Liebschutz, Kevin L. Kraemer, Ariana Freund and Raagini Jawa
    Citation: Harm Reduction Journal 2023 20:163
  40. Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised b...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick and Annette Binder
    Citation: Harm Reduction Journal 2023 20:162
  41. The methodological part of the large-scale study on the psychosocial distress of young people in Slovenia focused on vulnerable young people who use drugs and explored the potential of online interventions in ...

    Authors: Matej Sande, Bojan Dekleva, Špela Razpotnik, Darja Tadič, Mija Marija Klemenčič Rozman and Jana Rapuš Pavel
    Citation: Harm Reduction Journal 2023 20:161
  42. Providing sterile drug smoking materials to people who use drugs can prevent the acquisition of infectious diseases and reduce overdose risk. However, there is a lack of understanding of how these practices ar...

    Authors: Abigail Tapper, Catherine Ahern, Zoe Graveline-Long, Noam G. Newberger and Jaclyn M. W. Hughto
    Citation: Harm Reduction Journal 2023 20:160
  43. Opioid overdose deaths are of great concern to public health, with over one million lives lost since 1999. While many efforts have been made to mitigate these, Black communities continue to experience a greate...

    Authors: Dong-Chul Seo, Naomi Satterfield, Leonardo Alba-Lopez, Shin Hyung Lee, Charlotte Crabtree and Nicki Cochran
    Citation: Harm Reduction Journal 2023 20:159
  44. Opioid withdrawal is a regular occurrence among many people who use illicit opioids (PWUIO) that has also been shown to increase their willingness to engage in risk-involved behavior. The proliferation of fent...

    Authors: David Frank, Luther Elliott, Charles M. Cleland, Suzan M. Walters, Paul J. Joudrey, Danielle M. Russell, Beth E. Meyerson and Alex S. Bennett
    Citation: Harm Reduction Journal 2023 20:158
  45. Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe serv...

    Authors: April M. Ballard, Dylan Falk, Harris Greenwood, Paige Gugerty, Judith Feinberg, Peter D. Friedmann, Vivian F. Go, Wiley D. Jenkins, P. Todd Korthuis, William C. Miller, Mai T. Pho, David W. Seal, Gordon S. Smith, Thomas J. Stopka, Ryan P. Westergaard, William A. Zule…
    Citation: Harm Reduction Journal 2023 20:157